Please login to the form below

Not currently logged in
Email:
Password:

crenezumab

This page shows the latest crenezumab news and features for those working in and with pharma, biotech and healthcare.

Double blow to amyloid drug hopes as Roche, Lilly trial fails

Double blow to amyloid drug hopes as Roche, Lilly trial fails

Roche is also running a trial of another anti-amyloid antibody called crenezumab in an extended family in Colombia that are genetically predisposed to develop the disease due to PSEN1 mutations, ... Last year however crenezumab failed the phase 3 CREAD 1

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...

Infographics